Author:
Jobes David A.,Rizvi Shireen L.
Abstract
Around the world, suicide ideation, attempts, and deaths pose a major public and mental health challenge for patients (and their loved ones). Accordingly, there is a clear need for effective clinical treatments that reliably reduce suicidal thoughts and behaviors. In this article, we review the Collaborative Assessment and Management of Suicidality (CAMS) and Dialectical Behavior Therapy (DBT), two clinical treatments that rise to the highest levels of empirical rigor. Both CAMS and DBT are now supported by randomized controlled trials (RCTs), with independent replications, and meta-analyses. There are also supportive data related to training clinical providers to use CAMS and DBT with adherence. RCTs that investigate the use of both interventions within clinical trial research designs and the increasing use of these complementary approaches within routine clinical practice are discussed. Future directions for research and clinical use of CAMS and DBT are explored as means to effectively treat suicidal risk.
Reference65 articles.
1. World Health OrganizationSuicide Worldwide in 2019: Global Health Estimates2021
2. 2022 NSDUH Annual National Report
3. How many people are exposed to suicide? Not six;Cerel;Suicide Life Threat Behav,2019
4. Facts about suicideCDCSuicide
5. Rehospitalization of suicidal adolescents in relation to course of suicidal ideation and future suicide attempts;Czyz;Psychiatr Serv,2016